[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"company:BIO":3,"prompts:company:0000012208":25,"buybacks:0000012208:12":52,"months:0000012208:36":98,"side:events:0000012208":128,"filings:0000012208":140},{"status":4,"company":5,"choices":23,"suggestions":24},"found",{"cik":6,"name":7,"ticker":8,"exchange":9,"listings":10,"delisted":18,"coverage":19},"0000012208","Bio-Rad Laboratories, Inc.","BIO","NYSE",[11,15],{"ticker":8,"glr_ticker":12,"exchange":9,"type":13,"delisted_on":14},"NYSE:BIO","Common Stock",null,{"ticker":16,"glr_ticker":17,"exchange":9,"type":13,"delisted_on":14},"BIO.B","NYSE:BIO.B",false,{"buybacks":20},{"published":21,"published_at":22},true,"2026-11-17",[],[],{"placement":26,"items":27},"company",[28,33,37,41,47],{"id":29,"title":30,"hint":31,"kind":32,"question":30,"target":14},"asr-3nc2","How does a 3nc2 ASR look for me?","Pricer · discount, size vs. ADV","analyze",{"id":34,"title":35,"hint":36,"kind":32,"question":35,"target":14},"compare-3nc2-6nc4","Compare 3nc2 vs 6nc4","Two pricers side by side",{"id":38,"title":39,"hint":40,"kind":32,"question":39,"target":14},"backtest-2y","Backtest an ASR over 2 years","Backtest · chart",{"id":42,"title":43,"hint":44,"kind":45,"question":14,"target":46},"outstanding","What do I have outstanding?","Public · no email needed","page","buybacks#outstanding",{"id":48,"title":49,"hint":50,"kind":51,"question":14,"target":14},"convert-terms","Terms for a new convert","Coming next","soon",{"company":53,"data_as_of":54,"checked_at":55,"has_active_program":21,"authorized_total":56,"remaining_total":64,"nearest_expiration":66,"programs":68,"recent_quarters":82,"did_asr":18,"asrs":97},{"cik":6,"name":7,"ticker":8,"exchange":9},"2026-09-30","2026-11-18T05:12:55.977915Z",{"value":57,"status":58,"as_of":54,"source":59},206000000,"reported",{"accession":60,"form":61,"as_of":54,"filed_at":62,"url":63},"0000012208-26-000058","10-Q","2026-11-04","https:\u002F\u002Fwww.sec.gov\u002FArchives\u002Fedgar\u002Fdata\u002F12208\u002F000001220826000058\u002F",{"value":57,"status":58,"as_of":54,"source":65},{"accession":60,"form":61,"as_of":54,"filed_at":62,"url":63},{"value":14,"status":67,"as_of":14,"source":14},"not_found",[69],{"authorized":70,"unit":72,"authorized_as_stated":73,"price_as_of":14,"date_authorized":75,"expiration_date":76,"remaining":77,"remaining_as_stated":79,"description":81},{"value":57,"status":58,"as_of":54,"source":71},{"accession":60,"form":61,"as_of":54,"filed_at":62,"url":63},"usd",{"value":57,"status":58,"as_of":54,"source":74},{"accession":60,"form":61,"as_of":54,"filed_at":62,"url":63},{"value":14,"status":67,"as_of":14,"source":14},{"value":14,"status":67,"as_of":14,"source":14},{"value":57,"status":58,"as_of":54,"source":78},{"accession":60,"form":61,"as_of":54,"filed_at":62,"url":63},{"value":57,"status":58,"as_of":54,"source":80},{"accession":60,"form":61,"as_of":54,"filed_at":62,"url":63},"As of September 30, 2026, $206.0 million of stock remained available for repurchases under the Company's 2023 Share Repurchase Program, which was authorized by the Board of Directors in July 2023 and July 2024.",[83,87],{"period_start":84,"period_end":54,"shares":85,"avg_price":14,"value_usd":85,"source":86},"2026-07-01",0,{"accession":60,"form":61,"as_of":54,"filed_at":62,"url":63},{"period_start":88,"period_end":89,"shares":90,"avg_price":91,"value_usd":92,"source":93},"2026-04-01","2026-06-30",110428,281.56897109428763,31093098.339999996,{"accession":94,"form":61,"as_of":89,"filed_at":95,"url":96},"0000012208-26-000048","2026-08-04","https:\u002F\u002Fwww.sec.gov\u002FArchives\u002Fedgar\u002Fdata\u002F12208\u002F000001220826000048\u002F",[],{"company":99,"data_as_of":54,"items":100},{"cik":6,"name":7,"ticker":8,"exchange":9},[101,108,115,118,121,125],{"period_start":88,"period_end":102,"open_market_shares":103,"total_shares":103,"program_shares":103,"asr_shares":14,"avg_price":104,"value_usd":105,"remaining":106,"remaining_unit":72,"source":107},"2026-04-30",104853,281.78,29545478.339999996,207600000,{"accession":94,"form":61,"as_of":89,"filed_at":95,"url":96},{"period_start":109,"period_end":110,"open_market_shares":111,"total_shares":111,"program_shares":111,"asr_shares":14,"avg_price":112,"value_usd":113,"remaining":57,"remaining_unit":72,"source":114},"2026-05-01","2026-05-31",5575,277.6,1547620.0000000002,{"accession":94,"form":61,"as_of":89,"filed_at":95,"url":96},{"period_start":116,"period_end":89,"open_market_shares":85,"total_shares":85,"program_shares":85,"asr_shares":14,"avg_price":85,"value_usd":85,"remaining":57,"remaining_unit":72,"source":117},"2026-06-01",{"accession":94,"form":61,"as_of":89,"filed_at":95,"url":96},{"period_start":84,"period_end":119,"open_market_shares":85,"total_shares":85,"program_shares":85,"asr_shares":14,"avg_price":85,"value_usd":85,"remaining":57,"remaining_unit":72,"source":120},"2026-07-31",{"accession":60,"form":61,"as_of":54,"filed_at":62,"url":63},{"period_start":122,"period_end":123,"open_market_shares":85,"total_shares":85,"program_shares":85,"asr_shares":14,"avg_price":85,"value_usd":85,"remaining":57,"remaining_unit":72,"source":124},"2026-08-01","2026-08-31",{"accession":60,"form":61,"as_of":54,"filed_at":62,"url":63},{"period_start":126,"period_end":54,"open_market_shares":85,"total_shares":85,"program_shares":85,"asr_shares":14,"avg_price":85,"value_usd":85,"remaining":57,"remaining_unit":72,"source":127},"2026-09-01",{"accession":60,"form":61,"as_of":54,"filed_at":62,"url":63},{"view":129,"sort":130,"total":131,"generated_at":132,"items":133,"next_cursor":14},"all","newest",1,"2026-11-20T10:02:28.348033Z",[134],{"id":135,"type":136,"event_date":89,"company":137,"amount_usd":92,"amount_estimated":18,"shares":90,"headline":138,"source":139},"99f61480-6e04-5b97-8472-bd686c235b1c","quarterly_repurchase",{"cik":6,"name":7,"ticker":8,"exchange":9},"Bio-Rad Laboratories, Inc. repurchased 110,428 shares ($31m) in the quarter to Jun 30, 2026",{"accession":94,"form":61,"as_of":89,"filed_at":95,"url":96},{"company":141,"items":142,"edgar_url":152},{"cik":6,"name":7,"ticker":8,"exchange":9},[143,149],{"accession":60,"form":61,"filed_at":144,"period_end":54,"url":63,"used_for":145},"2026-11-04T16:19:18Z",[146,147,148],"programs","recent_quarters","remaining_total",{"accession":94,"form":61,"filed_at":150,"period_end":89,"url":96,"used_for":151},"2026-08-04T16:20:53Z",[147],"https:\u002F\u002Fwww.sec.gov\u002Fcgi-bin\u002Fbrowse-edgar?action=getcompany&CIK=0000012208"]